Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases
Background: The aspirin exacerbated respiratory disease (AERD) shows a prevalence of 7% among asthmatics and increases to 14% in patients with difficult to control asthma. Treatment includes the use of inhibitors of leukotriene receptor (), intranasal steroids, polypectomy, asthma management accordi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2016-05-01
|
| Series: | Revista Alergia México |
| Subjects: | |
| Online Access: | http://revistaalergia.mx/ojs/index.php/ram/article/view/151 |
| _version_ | 1797723015558987776 |
|---|---|
| author | Julio César Cambray-Gutiérrez Ulises Noel García-Ramírez Leonel Gerardo Del Rivero-Hernández Sean Alejandro Lozano-Martínez Patricia López-Pérez Aurora Alejandra Chávez-García |
| author_facet | Julio César Cambray-Gutiérrez Ulises Noel García-Ramírez Leonel Gerardo Del Rivero-Hernández Sean Alejandro Lozano-Martínez Patricia López-Pérez Aurora Alejandra Chávez-García |
| author_sort | Julio César Cambray-Gutiérrez |
| collection | DOAJ |
| description | Background: The aspirin exacerbated respiratory disease (AERD) shows a prevalence of 7% among asthmatics and increases to 14% in patients with difficult to control asthma. Treatment includes the use of inhibitors of leukotriene receptor (), intranasal steroids, polypectomy, asthma management according to the severity and avoid taking nonsteroidal anti-inflammatory drugs (NSAIDs). In some patients it is necessary desensitization protocol to it.
Clinical cases: two patients diagnosed with respiratory disease exacerbated by aspirin, with poor asthma control and need for multiple polypectomies, despite optimal pharmacological management, carrying out protocol desensitization to aspirin (AAS) successful, now after 4 years of having carried out, they have adequate asthma control without need for polypectomies with a maintenance dose of aspirin 150 mg/day. |
| first_indexed | 2024-03-12T09:57:02Z |
| format | Article |
| id | doaj.art-038cca0a7d4449f6878e193a927e55b2 |
| institution | Directory Open Access Journal |
| issn | 0002-5151 2448-9190 |
| language | English |
| last_indexed | 2024-03-12T09:57:02Z |
| publishDate | 2016-05-01 |
| publisher | Colegio Mexicano de Inmunología Clínica y Alergia, A.C. |
| record_format | Article |
| series | Revista Alergia México |
| spelling | doaj.art-038cca0a7d4449f6878e193a927e55b22023-09-02T12:04:43ZengColegio Mexicano de Inmunología Clínica y Alergia, A.C.Revista Alergia México0002-51512448-91902016-05-0163220721210.29262/ram.v63i2.151120Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical casesJulio César Cambray-Gutiérrez0Ulises Noel García-Ramírez1Leonel Gerardo Del Rivero-Hernández2Sean Alejandro Lozano-Martínez3Patricia López-Pérez4Aurora Alejandra Chávez-García5Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Alergia e Inmunología Clínica, Ciudad de MéxicoInstituto Mexicano del Seguro Social, Centro Médico Nacional del Bajío, Hospital de Especialidades, León, GuanajuatoInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Alergia e Inmunología Clínica, Ciudad de MéxicoInstituto Mexicano del Seguro Social, Centro Médico Nacional del Bajío, Hospital de Especialidades, León, GuanajuatoInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Alergia e Inmunología Clínica, Ciudad de MéxicoInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Alergia e Inmunología Clínica, Ciudad de MéxicoBackground: The aspirin exacerbated respiratory disease (AERD) shows a prevalence of 7% among asthmatics and increases to 14% in patients with difficult to control asthma. Treatment includes the use of inhibitors of leukotriene receptor (), intranasal steroids, polypectomy, asthma management according to the severity and avoid taking nonsteroidal anti-inflammatory drugs (NSAIDs). In some patients it is necessary desensitization protocol to it. Clinical cases: two patients diagnosed with respiratory disease exacerbated by aspirin, with poor asthma control and need for multiple polypectomies, despite optimal pharmacological management, carrying out protocol desensitization to aspirin (AAS) successful, now after 4 years of having carried out, they have adequate asthma control without need for polypectomies with a maintenance dose of aspirin 150 mg/day.http://revistaalergia.mx/ojs/index.php/ram/article/view/151enfermedad respiratoriaaspirinadesensibilización |
| spellingShingle | Julio César Cambray-Gutiérrez Ulises Noel García-Ramírez Leonel Gerardo Del Rivero-Hernández Sean Alejandro Lozano-Martínez Patricia López-Pérez Aurora Alejandra Chávez-García Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases Revista Alergia México enfermedad respiratoria aspirina desensibilización |
| title | Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases |
| title_full | Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases |
| title_fullStr | Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases |
| title_full_unstemmed | Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases |
| title_short | Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases |
| title_sort | long term efficacy of aspirin desensitization in aspirin exacerbated respiratory disease review of two clinical cases |
| topic | enfermedad respiratoria aspirina desensibilización |
| url | http://revistaalergia.mx/ojs/index.php/ram/article/view/151 |
| work_keys_str_mv | AT juliocesarcambraygutierrez longtermefficacyofaspirindesensitizationinaspirinexacerbatedrespiratorydiseasereviewoftwoclinicalcases AT ulisesnoelgarciaramirez longtermefficacyofaspirindesensitizationinaspirinexacerbatedrespiratorydiseasereviewoftwoclinicalcases AT leonelgerardodelriverohernandez longtermefficacyofaspirindesensitizationinaspirinexacerbatedrespiratorydiseasereviewoftwoclinicalcases AT seanalejandrolozanomartinez longtermefficacyofaspirindesensitizationinaspirinexacerbatedrespiratorydiseasereviewoftwoclinicalcases AT patricialopezperez longtermefficacyofaspirindesensitizationinaspirinexacerbatedrespiratorydiseasereviewoftwoclinicalcases AT auroraalejandrachavezgarcia longtermefficacyofaspirindesensitizationinaspirinexacerbatedrespiratorydiseasereviewoftwoclinicalcases |